Brought to you by 
Dura's new funding vehicle Spiros II completes IPO
11 Sep 2000
Executive Summary
Spiros Development Corp. II, the financing vehicle Dura Pharmaceuticals formed 9/97 to fund development of its Spiros dry powder pulmonary drug delivery systems, raised net proceeds of $81.8mm in an IPO of 5.5mm units at $16 per unit.
Deal Industry
- Medical Devices
-
Pharmaceuticals
-
Drug Delivery
- Pulmonary
-
Drug Delivery
Deal Status
- Withdrawn
Deal Type
-
Financing
- Special-Purpose Financing Vehicle
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Dura's new funding vehicle Spiros II completes IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice